The Latest Analyst Ratings for RxSight
Portfolio Pulse from Benzinga Insights
RxSight (NASDAQ:RXST) has received 4 bullish and 2 indifferent analyst ratings in the last quarter. The average price target is $26.0, which is lower than the current price of $30.77. The average price target has increased by 22.64% over the past month.
July 12, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RxSight has received mostly bullish ratings from analysts, but the average price target suggests a potential downside.
The bullish ratings indicate a positive outlook for RxSight. However, the average price target is lower than the current price, suggesting that the stock may be overvalued and could experience a price correction in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100